Gianluigi Cardinali

Gianluigi Cardinali is a faculty member at the University of Perugia, specifically within the Department of Agricultural, Food and Environmental Sciences, School of Agricultural, Food and Environmental Sciences. He serves as Coordinator of the Doctoral Program in Biotechnology, indicating a leadership role in academic training and research supervision.

His research spans microbial biotechnology, yeast genetics, fungal biofilms, DNA barcoding, and sustainable agriculture. Key interests include plant-microbe interactions, industrial and medical mycology, metabolomics, and environmental microbiology. His work bridges fundamental science with practical applications in agriculture, food safety, and biomedicine.

The recent publications (2023–2025) highlight a strong focus on sustainable solutions using microbial life, including waste valorization from olive oil and hemp, salt stress mitigation in crops using plant growth-promoting yeasts, and antimicrobial strategies against Candida biofilms using natural extracts and novel biomaterials. There is a consistent emphasis on molecular identification techniques such as NGS, DNA barcoding, and multi-omics approaches (metabolomics, proteomics) to study microbial diversity and function.

No scientific awards are explicitly mentioned in the provided text.

Dr. Cardinali advises doctoral students as Coordinator of the Biotechnology PhD program and likely leads a research group focused on microbial biotechnology and fungal systems. His extensive publication record in high-impact areas suggests active grant funding, though specific grants are not listed. His research integrates laboratory experimentation with ecological and systems-level analysis, promoting interdisciplinary approaches.

His laboratory appears to specialize in microbial identification using advanced spectroscopic (Raman, FT-IR), sequencing (NGS, MinION), and metabolomic techniques. The team investigates both environmental and clinical fungal strains, with applications spanning agriculture, food, and medicine. Research infrastructure likely includes facilities for yeast genetics, biofilm studies, and omics analysis.